
Domainex Ltd is a contract research company that was established in 2001 and operates from Cambridge UK. In May 2007 Domainex merged with NCE Discovery to form a new integrated company with capabilities in biology and chemistry.
Our service division offers technologies designed to clone and express challenging genes to give high-quality recombinant protein displaying functional domains of the target. We also provide computational and medicinal chemistry for the design and synthesis of candidate drugs aimed at our customers' target proteins.
Our drug discovery division seeks to exploit these technologies and expertise against a small portfolio of our own projects. Our internal programmes are exclusively focussed on nucleotide triphosphate binding domains (NTP domains) which are found in several important therapeutic targets.